Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L.
Chen X, et al. Among authors: li z, li r.
Signal Transduct Target Ther. 2020 Sep 2;5(1):180. doi: 10.1038/s41392-020-00301-9.
Signal Transduct Target Ther. 2020.
PMID: 32879307
Free PMC article.